I think Nuvaring was accepted around 20 March 2018, so we expect the FDA review by 20 January 2019. Not long now... I think the market may have been spooked by CEO commentary that they are handling a number of review questions by FDA re Nuvaring application, but this is very standard for most applications. I think it is coming soon and if that doesn't put a rocket under the SP nothing will!
$2 here we come...., page-470
-
- There are more pages in this discussion • 551 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.03 |
Change
-0.190(4.50%) |
Mkt cap ! $342.8M | |||
| Open | High | Low | Value | Volume |
| $4.10 | $4.22 | $4.02 | $1.235M | 303.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $4.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.04 | 164 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |